Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
Clinical Research Institute · Duke Medical Center · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
723
total citations
- FWCI
- 69.40
- Percentile
- 100%
- References
- 21
Citations per year
Authors
35Topics & keywords
Topics
Keywords
- Interleukin 28B
- Internal medicine
- Medicine
- Ribavirin
- Odds ratio
- Gastroenterology
- Pegylated interferon
- Confidence interval
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.